David F. Hendry
Papers
2
Total Citations
346
H-Index
2
About
David F. Hendry is a leading urologic oncologist whose research has fundamentally reshaped the surgical management of bladder cancer. His primary focus lies in comparing robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion against the traditional open approach, rigorously evaluating both clinical outcomes and economic value. His landmark 2022 study, published in the *Journal of Clinical Oncology* and cited over 320 times, was a pivotal randomized controlled trial demonstrating that while robot-assisted surgery reduces hospital stay and transfusions, it does not significantly lower 90-day morbidity or mortality compared to open surgery—a finding that has tempered enthusiasm for the costly technology. Building on this, his 2023 cost-effectiveness analysis (26 citations) provided crucial data for payers and policymakers, showing that the robotic approach offers only marginal value at current prices. Dr. Hendry’s work is notable for its methodological rigor and direct impact on clinical guidelines, helping surgeons and patients make evidence-based decisions about surgical approach. His contributions have established him as a key voice in the debate over surgical innovation and healthcare economics in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2